Catheter Precision (VTAK) Expected to Announce Earnings on Friday

Catheter Precision (NYSEAMERICAN:VTAKGet Free Report) is anticipated to post its quarterly earnings results before the market opens on Friday, April 4th. Analysts expect Catheter Precision to post earnings of ($0.20) per share and revenue of $0.28 million for the quarter.

Catheter Precision Trading Up 1.5 %

Shares of VTAK stock opened at $0.35 on Wednesday. Catheter Precision has a twelve month low of $0.30 and a twelve month high of $8.40. The company has a debt-to-equity ratio of 0.12, a current ratio of 0.66 and a quick ratio of 0.65. The stock has a fifty day moving average price of $0.39.

About Catheter Precision

(Get Free Report)

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.

See Also

Earnings History for Catheter Precision (NYSEAMERICAN:VTAK)

Receive News & Ratings for Catheter Precision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catheter Precision and related companies with MarketBeat.com's FREE daily email newsletter.